CBD Oil Benefits UK: What Does the Research Actually Show?

June 22, 2026

Does CBD Oil Have Proven Health Benefits?

People searching for the benefits of CBD oil are often presented with long lists claiming CBD helps pain, anxiety, sleep, inflammation, skin conditions and many other health problems.

The scientific picture is more complicated.

CBD is being investigated in many areas of medicine, and there are some genuine and important findings. There is even a licensed prescription medicine containing purified cannabidiol for particular forms of severe epilepsy.

But that does not mean an ordinary retail CBD oil has seven, ten or twenty proven health benefits.

For CBD products sold as foods or food supplements in the UK, the Food Standards Agency states that there are currently no authorised CBD health claims and that claims that CBD foods relieve pain, improve sleep or treat illness are not permitted. Read the current FSA guidance.

The useful question is therefore not:

“What are the seven proven benefits of CBD?”

It is:

“What has actually been studied, how strong is the evidence, and does that research apply to retail CBD oil?”

Here are seven of the areas people most commonly ask about.

1. CBD and Pain: What Does the Research Show?

Pain is one of the most common reasons people become interested in CBD.

Cannabinoids have been investigated in numerous types of pain, but different studies have used different compounds, doses and patient groups. Research involving THC, THC/CBD medicines or other cannabinoids cannot automatically be treated as evidence for CBD isolate.

NICE's current cannabis-based medicinal-products guideline says CBD should not be offered to adults for chronic pain unless it is part of a clinical trial. The guideline was reviewed again in May 2025 and the recommendation remained in place. Read NICE guideline NG144.

This does not mean pain research has stopped. It means the evidence is not strong enough to turn CBD into a routinely recommended chronic-pain treatment.

We examine individual trials and their limitations in our separate CBD Oil and Pain UK: What Does the Research Show? guide.

That specialist page should own the detailed CBD-and-pain discussion rather than repeating all of it here.

2. CBD and Anxiety: Promising Research, but Not a Proven Benefit

Anxiety is another heavily marketed use of CBD.

There have been randomized controlled trials investigating CBD in different anxiety settings. A 2024 systematic review identified 11 randomized controlled trials, but the studies varied substantially in the anxiety conditions investigated, doses used and study designs.

The reviewers described the results as often contradictory. Some studies suggested possible reductions in anxiety, but the authors concluded that better controlled research is still required. Read the systematic review on PubMed.

That is quite different from saying CBD oil has been proven to reduce anxiety.

It is also why customer statements such as “CBD takes the edge off” should not be converted into a health claim about a Valley CBD product.

Our dedicated CBD and Anxiety UK guide looks at this research separately.

3. CBD and Sleep: What Have Human Trials Found?

CBD is widely sold online as though better sleep were an established benefit.

Human research is much less certain.

A randomized placebo-controlled 2024 pilot trial investigated 150mg CBD nightly in 30 people with moderate-to-severe primary insomnia.

CBD was similar to placebo for most of the major sleep outcomes, including insomnia severity, self-reported time taken to fall asleep, sleep efficiency and waking after sleep onset. Some secondary measures differed, but the researchers concluded that more controlled studies were needed. Read the insomnia trial on PubMed.

The 150mg used in that research was a clinical-study dose and should not be copied as retail dosing guidance.

The FSA specifically states that claims that CBD foods improve sleep are not permitted.

We examine the sleep evidence in greater detail in CBD Oil for Sleep UK: What Does the Research Actually Say?

4. What About CBD and Inflammation?

CBD has attracted considerable scientific interest because laboratory and animal research has identified effects on biological pathways involved in inflammatory processes.

That makes inflammation a legitimate field of research.

But biological mechanisms are not the same thing as a proven benefit in people.

An experiment showing that CBD affects inflammatory signalling in cells or reduces an inflammatory response in an animal model cannot establish that taking a retail CBD oil reduces inflammation in somebody with arthritis, fibromyalgia, a sports injury or another health condition.

This distinction was missing from the old version of this article.

It previously moved from preclinical research directly to recommending higher-strength CBD oil and the Valley CBD balm for inflammatory conditions.

That conclusion is not justified.

We will audit our separate inflammation article independently because it deserves its own careful evidence review rather than importing its current claims into this page.

5. CBD and Epilepsy: An Important Proven Medical Use — With an Important Difference

This is perhaps the clearest example of why the word CBD can cause confusion.

There genuinely is a licensed cannabidiol medicine.

Epidyolex is a purified cannabidiol medicine used with clobazam for seizures associated with particular severe epilepsies, including Lennox–Gastaut syndrome and Dravet syndrome. NICE recommends cannabidiol with clobazam in specified circumstances. Read NICE guidance.

That is powerful evidence that cannabidiol can have genuine pharmacological and medical effects.

But Epidyolex is a regulated medicine with a specific formulation, dose, indication and clinical evidence.

The UK Government explicitly distinguishes Epidyolex from commercially available CBD supplements that have not obtained marketing authorisation as medicines. Read the UK Government advice on Epidyolex.

It would therefore be incorrect to reason:

“Prescription CBD helps certain severe epilepsies, therefore ordinary CBD oil has proven general health benefits.”

Those are two very different propositions.

Valley CBD products are retail CBD-isolate products, not Epidyolex and not substitutes for prescription epilepsy medication.

6. CBD and Skin: Is Topical Research Promising?

The skin has become another active area of cannabinoid research.

Studies have investigated CBD and other cannabinoid formulations for conditions including dermatitis, psoriasis, itching and acne.

But the clinical evidence is still developing.

A 2025 systematic review and meta-analysis examined cannabinoid interventions across dermatological studies. It found a modest improvement in itching, but did not find significant benefits for several other outcomes, including skin dryness, quality of life and disease-specific atopic-dermatitis scores. Read the review on PubMed.

Another systematic review of topical and transdermal CBD research warned that trials used very different formulations and methodologies, often had a high risk of bias, and should not be generalised to every CBD preparation. Read the topical CBD review on PubMed.

This is precisely why we should not say a retail CBD balm treats eczema, psoriasis or acne merely because CBD has been investigated in dermatology.

Promising research is worth discussing.

It is not the same thing as a proven product benefit.

7. Does CBD Help With Nausea?

This topic creates another easy cannabinoid/CBD mix-up.

Cannabis-based medicines have been investigated for chemotherapy-induced nausea and vomiting, and NICE says nabilone can be considered as an add-on treatment in adults whose chemotherapy-related nausea and vomiting persists despite optimised conventional anti-sickness treatment. Read NICE information for the public.

But nabilone is a synthetic cannabinoid medicine.

It is not ordinary retail CBD oil.

So evidence supporting nabilone in a particular medical setting cannot be used to claim that a CBD food supplement provides nausea relief.

Our current standalone nausea article is therefore another page that we will review separately rather than using it as evidence for a “CBD benefit” here.

Why Scientific Research and CBD Product Claims Are Different

It is perfectly reasonable to study CBD.

It is also reasonable for a CBD retailer to explain that research accurately.

Problems arise when a study becomes a sales claim.

For example:

A clinical trial investigates CBD in a particular disease. That does not automatically establish that Valley CBD oil treats that disease.
A topical CBD formulation produces an interesting result. That does not establish that every CBD balm produces the same result.
A prescription cannabidiol medicine is effective for a particular form of epilepsy. That does not establish that retail CBD oil has the same medical use.
A laboratory experiment identifies an anti-inflammatory mechanism. That does not prove somebody taking CBD oil will experience reduced inflammation.

The formulation, dose, route of administration, population, study design and regulatory status all matter.

Does Higher-Strength CBD Mean Greater Benefits?

No evidence supports treating CBD concentration as a measure of medical effectiveness.

A 40% CBD oil contains more CBD per millilitre than a 10% CBD oil.

That is what the percentage tells you.

It does not tell you that the 40% oil is four times better for pain, sleep, anxiety, inflammation or another health outcome.

The old version of this article suggested that 3000mg+ oils and 5000mg+ balms produced more noticeable benefits.

That claim has been removed.

People who want to understand CBD percentages can instead use our dedicated CBD Oil Strength Guide.

That keeps concentration separate from medical effectiveness.

What Can You Meaningfully Compare Between CBD Products?

Even when we avoid health claims, there are plenty of useful product characteristics consumers can compare.

These include the amount of CBD in the bottle, CBD concentration in mg/ml, whether the product uses isolate or another type of extract, ingredients, flavour, bottle size, price, laboratory documentation and whether the label clearly explains what the customer is buying.

Those are measurable product characteristics.

They do not require us to promise that one product will relieve a particular symptom.

This is also a much better basis for comparing Valley CBD with another retailer than trying to win by making stronger health claims.

What Does the FSA Currently Recommend About CBD Intake?

The Food Standards Agency updated its CBD consumer advice on 22 June 2026.

For healthy adults consuming CBD foods, its current advice is to limit total CBD consumption to 10mg per day.

The FSA advises people taking medication not to consume CBD unless under medical direction because CBD can interact with some medicines.

It also advises people who are pregnant, trying to conceive or breastfeeding, people with underlying health conditions, and other vulnerable groups to avoid CBD unless under medical direction.

These recommendations are consumer-safety guidance.

They should not be confused with the much higher doses sometimes used in clinical research.

Frequently Asked Questions

What are the proven benefits of CBD oil?

For ordinary CBD foods and food supplements sold in the UK, there are currently no authorised CBD health claims.

CBD is being studied in many areas, and purified cannabidiol is used as a licensed medicine for certain severe epilepsies, but that does not establish general medical benefits for retail CBD oil.

Is CBD proven to help with pain?

CBD and other cannabinoids have been extensively researched for pain, but NICE currently says CBD should not be offered to adults to manage chronic pain unless it is part of a clinical trial.

Is CBD proven to reduce anxiety?

No general anxiety benefit has been established for retail CBD oil. A 2024 systematic review of randomized CBD trials found mixed and sometimes contradictory results, although some studies produced promising findings.

Is CBD proven to improve sleep?

No. In a 2024 randomized pilot trial involving primary insomnia, 150mg CBD was similar to placebo for most major sleep outcomes. More research is needed.

Does CBD reduce inflammation?

CBD has biological effects that make inflammation an active area of scientific research, but laboratory and animal findings should not be presented as proof that retail CBD oil treats inflammatory conditions in people.

Does stronger CBD have more benefits?

Higher strength means more CBD per unit of product. It does not mean more proven health benefits.

If CBD is a prescription medicine, why can't retail CBD make the same claims?

Medicines such as Epidyolex have undergone pharmaceutical development, clinical testing and regulatory authorisation for specific conditions.

The UK Government explicitly distinguishes licensed cannabidiol medicines from ordinary commercial CBD supplements.

The Bottom Line

CBD is scientifically interesting, and serious research is taking place in areas including pain, anxiety, sleep, epilepsy, inflammation and dermatology.

Some findings are promising.

Some trials have been negative.

Some of the strongest evidence relates to specific prescription medicines, rather than ordinary CBD food supplements.

That is why a responsible answer to “What are the benefits of CBD oil?” needs more nuance than a list of seven promises.

For Valley CBD, our approach is simple:

we explain the evidence, distinguish research products from retail CBD, and avoid turning scientific interest into medical claims about the products we sell.

That gives customers more useful information while staying consistent with current UK guidance.

This article is for general educational information only and is not medical advice. Valley CBD food supplements are not intended to diagnose, treat, cure or prevent disease.

Sources

Back to blog

Country/region